11C-choline PET/CT and whole-body MRI including diffusion-weighted imaging for patients with recurrent prostate cancer-Reference-Cited by-同舟云学术

11C-choline PET/CT and whole-body MRI including diffusion-weighted imaging for patients with recurrent prostate cancer

Published:2017-03-15 Issue:39 Volume:8 Page:66516-66527
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wieder Hinrich¹²,Beer Ambros J.¹³,Holzapfel Konstantin⁴,Henninger Martin¹,Maurer Tobias⁵,Schwarzenboeck Sarah⁶,Rummeny Ernst J.⁴,Eiber Matthias¹,Stollfuss Jens⁴⁷

Affiliation:

1. Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

2. Centre for Radiology and Nuclear Medicine, Grevenbroich, Germany

3. Department of Nuclear Medicine, Ulm University, Ulm, Germany

4. Institute for Diagnostic and Interventional Radiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

5. Department of Urology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

6. Department of Nuclear Medicine, Universitätsmedizin Rostock, Rostock, Germany

7. Department of Radiology and Nuclear Medicine, Klinikum Memmingen, Memmingen, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of diffusion-weighted MRI in the evaluation of imaging for prostate carcinoma: A systematic review;MGM Journal of Medical Sciences;2024-04

2. Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI;European Radiology;2023-12-01

3. Diagnosis of early biochemical recurrence after radical prostatectomy or radiation therapy in patients with prostate cancer: State of the art;Diagnostic and Interventional Imaging;2022-04

4. Whole-body MRI: detecting bone metastases from prostate cancer;Japanese Journal of Radiology;2021-10-25

5. Comparison of PET/CT and MRI in the Diagnosis of Bone Metastasis in Prostate Cancer Patients: A Network Analysis of Diagnostic Studies;Frontiers in Oncology;2021-10-04